​Hims & Hers Plunges After FDA Ends ‘Shortage’ Status Of Eli Lilly’s Weight-Loss Drug – Tyler Durden

Hims & Hers Plunges After FDA Ends ‘Shortage’ Status Of Eli Lilly’s Weight-Loss Drug On Wednesday, the Food and Drug Administration announced that the supply shortages of Eli Lilly’s popular weight-loss and diabetes drugs have been resolved. These drugs have been in short supply since the anti-obesity drug craze erupted several years ago. Now, an ample supply of GLP-1 drugs could signal that the ‘fat bubble’ in equity markets has popped.  FDA said that Lilly’s Zepbound and Mounjaro multi-year shortage is over, adding that there are “legal restrictions on making copies of FDA-approved drugs” when there isn’t a shortage.  FDA said Eli Lilly’s…  — Continue at ZeroHedge News : Read More